ReviewJournal of feline medicine and surgery2013
Cats with cancer: where to start.
Review in Journal of feline medicine and surgery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 21 citations in OpenAlex.
- Characterization of putative germline pathogenic variants in 27 candidate cancer-predisposing genes in 813 cats using a feline-specific multiplex targeted sequencing.Scientific reports · 2026Article
- Comparative Cancer Genetics and Veterinary Therapeutics in Dogs and Cats: A Species-Aware Framework for Comparative Oncology.Life (Basel, Switzerland) · 2026Review
- Factors influencing malignant tumor development in cats from a multicenter retrospective study.Scientific reports · 2026Article
- Veterinary pilot study on focused ultrasound treatment of spontaneous canine and feline tumours: technical and feasibility assessment.Journal of ultrasound · 2025Article
- Feline Lymphoma in Focus: Examining the Patterns and Types in Croatia's Pathological Records.Veterinary sciences · 2025Article
- From Lipid Signatures to Cellular Responses: Unraveling the Complexity of Melanoma and Furthering Its Diagnosis and Treatment.Medicina (Kaunas, Lithuania) · 2024Review
- Proof-of-concept evaluation of next-generation sequencing-based liquid biopsy for non-invasive cancer detection in cats.Frontiers in veterinary science · 2024Article
- Development of anti-feline PD-1 antibody and its functional analysis.Scientific reports · 2023Article
- Treatment of canine and feline sarcoma using MR-guided focused ultrasound system.Journal of ultrasound · 2022Article
- Salinomycin decreases feline sarcoma and carcinoma cell viability when combined with doxorubicin.BMC veterinary research · 2019Article
- Laparoscopic liver lobectomy in a cat.JFMS open reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
practical relevanceMany cats develop cancer and may or may not present with an obvious mass lesion. As our feline patients are living longer and their owners are increasingly seeking veterinary care, the apparent incidence and prevalence of cancer is increasing. CLINICAL CHALLENGES: Neoplasia is a differential for many clinical presentations in cats. Often tumours are relatively advanced at the point of presentation, and this can make management difficult. In addition, many cats find clinic visits stressful and this can influence owners' decisions about treatment. AUDIENCE: This review provides an overview of the approach to the feline cancer patient, and is aimed at all veterinary practitioners that see cats. It is intended as a starting point for more detailed discussions in accompanying articles in this special issue on feline oncology. EVIDENCE BASE: There is limited data on most feline tumours compared with tumours in canine or human patients, so a robust evidence base is often lacking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.